+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Leishmania major lipophosphoglycan modulates the phenotype and inhibits migration of murine Langerhans cells



Leishmania major lipophosphoglycan modulates the phenotype and inhibits migration of murine Langerhans cells



Immunology 104(4): 462-467



Langerhans cells (LC), members of the dendritic cell family, play a central role in the initiation and regulation of the immune response against the protozoan parasite Leishmania major. LC take up antigens in the skin and transport them to the regional lymph nodes for presentation to T cells. However, it is not known whether LC functions are modulated by parasite antigens. In the present study, we examined the effect of a major parasite surface molecule, L. major lipophosphoglycan (LPG), on the maturation of LC and their migratory properties. The results show that exposure to LPG did not affect the expression of major histocompatibility complex (MHC) class II and B7, but induced an up-regulation of CD25, CD31 and vascular endothelial (VE)-cadherin expression and a down-regulation of Mac-1 expression, by LC. Importantly, LPG treatment inhibited the migratory activity of LC, as it reduced their efflux from skin explants and their migration in transwell cultures. These results suggest that Leishmania LPG impairs LC migration out of the skin and thus may modulate their immunostimulatory functions, which require LC translocation from skin to lymph nodes.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 046536853

Download citation: RISBibTeXText

PMID: 11899433


Related references

Leishmania major (L. major ) lipophosphoglycan modulates the expression of co-stimulatory and cell-adhesion molecules by Langerhans cells. Biochemical Society Transactions 28(5): A234.1-A234, 2000

Leishmania major lipophosphoglycan modulates the expression of co-stimulatory and cell-adhesion molecules by Langerhans cells. Biochemical Society Transactions 28(5): A234, 2000

Leishmania major lipophosphoglycan modulates the expression of receptors involved in parasite internalization in skin Langerhans cells. Acta Cientifica Venezolana 53(3): 218-224, 2002

Migration of murine epidermal Langerhans cells to regional lymph nodes: engagement of major histocompatibility complex class II antigens induces migration of Langerhans cells. Microbiology and Immunology 38(7): 567-574, 1994

A lipophosphoglycan -deficient Leishmania major induces CD4-positive T cells which protect susceptible BALB/c mice against infection with virulent Leishmania major. Journal of Immunology 150(8 Part 2): 12A, 1993

Production of nitric oxide by murine macrophages induced by lipophosphoglycan of Leishmania major. Korean Journal of Parasitology 44(1): 35-41, 2006

Identification of truncated forms of lipophosphoglycan in mutant cloned lines of Leishmania major that are deficient in mature lipophosphoglycan. Parasitology Research 79(5): 435-438, 1993

CC chemokine receptor 2 is required for Langerhans cell migration and localization of T helper cell type 1 -inducing dendritic cells Absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 cytokines, B cell outgrowth, and sustained neutrophilic inflammation. Journal of Experimental Medicine 192(2): 205-218, 2000

CC chemokine receptor (CCR)2 is required for langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells. Absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 cytokines, b cell outgrowth, and sustained neutrophilic inflammation. Journal of Experimental Medicine 192(2): 205-218, 2000

Absence of CCR2 impairs Langerhans cell migration and shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 cytokines and B cell hyperactivity. FASEB Journal 14(6): A1028, 2000

Murine epidermal Langerhans cells are potent stimulators of an antigen-specific T cell response to Leishmania major, the cause of cutaneous leishmaniasis. European Journal of Immunology 22(6): 1341-1347, 1992

An avirulent lipophosphoglycan-deficient Leishmania major clone induces CD4+ T cells which protect susceptible BALB/c mice against infection with virulent L. major. Infection and Immunity 61(12): 5205-5213, 1993

Leishmania major-infected murine langerhans cell-like dendritic cells from susceptible mice release IL-12 after infection and vaccinate against experimental cutaneous Leishmaniasis. European Journal of Immunology 30(12): 3498-3506, 2000

Deficiency in 1,3-galactosyltransferase of a Leishmania major lipophosphoglycan mutant adversely influences the Leishmania-sand fly interaction. Journal of Biological Chemistry. August 23; 27134: 20573-20579, 1996

Deficiency in beta 1,3-galactosyltransferase of a Leishmania major lipophosphoglycan mutant adversely influences the Leishmania-sand fly interaction. Journal of biological chemistry 271(34): 20573-20579, 1996